Which of the following nutrients is critical for preventing neural tube defects?

Video Transcript

Hello students. So in this question they have asked which of the following elements or nutrients is critical for preventing neural tube defects. Now, what does this defect even mean? If we observe the neural tube defects, It means that in case of the spinal cord there is a problem. So what is the problem in the spinal cord? It fails to close properly, right? It fails to close properly. That is what is the neural tube defect in this case? What is the enzyme that is required or an element or a nutrient that is most critical for preventing this kind of defect? It is the folate right? Also known as the folic acid. So in this case we will write our answer as option B itself. Coming to the next question. In the next question, they have given that there's this woman who has gained £30 in the first two months of a pregnancy and as a result has diagnosed has been diagnosed with gestational diabetes. Right? So, in this case, what could be the possible explanation for this condition? If we observe the gestational diabetes here? What we basically see is that this individual is suffering from diabetes or will be suffering with diabetes only until she gives birth, right? Until she gives birth, she will be suffering with diabetes, right? So until she gives birth, what should she control the carbohydrates that she's going to be taking? Right? So based on that, we can say that the second option and the fourth option is the right answer because they have given that she needs to stop eating all kinds of food that contains carbohydrates to lower her blood glucose. Along with that the condition will go away post party rations right? That is why we can write our answer as option B and option the with suits best for the condition that they have mentioned. Coming to the next question. The incidence of chronic disease can be correlated with the single risk factor. Is this statement true efforts. Now, if we observe with respect to chronic disease, what do we see? We see that chronic diseases are the ones that will basically be correlated with Four risk factors. It's not just one but four risk factors. What are the four risk factors that you will observe? One is the tobacco which is happening due to smoking. The other one is alcohol consumption, which is again coming under drinking, right? And then you will observe nutrition the diet that you take, right? If it is poor based on that as well and the lack of physical activities such as exercise. So if these kind of things are not done properly or if some things are not taken care of, then we will observe an incidence of chronic disease. Right? So the statement they have given here, is it true or false? Absolutely false. Right. That is why that is what we are going to be writing in this case. I hope you understood the answer here, Thank you

1. Eitenmiller R., Landen W. Vitamin Analysis for the Health and Food Science. CRC Press; Baco Raton, FL, USA: 1999. Folate; pp. 411–465. [Google Scholar]

2. O’Broin J.D., Temperley I.J., Brown J.P., Scott J.M. Nutritional stability of various naturally occurring monoglutamate derivatives of folic acid. Am. J. Clin. Nutr. 1975;28:438–444. [PubMed] [Google Scholar]

3. Temple C., Montgomery J.A. Chemical and Physical Properties of Folic Acid and Reduced Derivatives. John Wiley; New York, NY, USA: 1984. [Google Scholar]

4. Stover P.J. Folate biochemical pathways and their regulation. In: Bailey L.B., editor. Folate in Health and Disease. 2nd. CRC Press, Taylor & Francis Group; Gainesville, FL, USA: 2009. pp. 49–74. [Google Scholar]

5. Molloy A.M., Brody L.C., Mills J.L., Scott J.M., Kirke P.N. The search for genetic polymorphisms in the homocysteine/folate pathway that contribute to the etiology of human neural tube defects. Birth Defects Res. A Clin. Mol. Teratol. 2009;85:285–294. [PMC free article] [PubMed] [Google Scholar]

6. Sutton M., Daly L.E., Kirke P.N. Survival and disability in a cohort of neural tube defect births in Dublin, Ireland. Birth Defects Res. A Clin. Mol. Teratol. 2008;82:701–709. [PubMed] [Google Scholar]

7. Hibbard B.M., Hibbard E.D., Jeffcoate T.N. Folic acid and reproduction. Acta Obstet. Gynecol. Scand. 1965;44:375–400. [PubMed] [Google Scholar]

8. Smithells R., Nevin N., Seller M., Sheppard S., Harris R., Read A., Fielding D., Walker S., Schorah C., Wild J. Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet. 1983;1:1027–1031. [PubMed] [Google Scholar]

9. Mulinare J., Cordero J.F., Erickson J.D., Berry R.J. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA. 1988;260:3141–3145. [PubMed] [Google Scholar]

10. Bower C., Stanley F.J. Dietary folate as a risk factor for neural-tube defects: evidence from a case-control study in Western Australia. Med. J. Aust. 1989;150:613–619. [PubMed] [Google Scholar]

11. MRC Vitamin Study Research Group., authors Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338:131–137. [PubMed] [Google Scholar]

12. Czeizel A.E., Dudas I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 1992;327:1832–1835. [PubMed] [Google Scholar]

13. Centers for Disease Control and Prevention, authors. Use of folic acid for prevention of spina bifida and other neural tube defects—1983–1991. MMWR Morb. Mortal. Wkly. Rep. 1991;40:513–516. [PubMed] [Google Scholar]

14. Centers for Disease Control and Prevention, authors. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm. Rep. 1992;41:1–7. [PubMed] [Google Scholar]

15. Institute of Medicine, authors. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. National Academy Press; Washington, DC, USA: 1998. Folate; pp. 196–305. [Google Scholar]

16. U.S. Preventive Services Task Force, authors. Folic acid for the prevention of neural tube defects: U.S. Preventive Services Task Force recommendation statement. Ann. Intern. Med. 2009;150:626–631. [PubMed] [Google Scholar]

17. Finer L.B., Henshaw S.K. Disparities in rates of unintended pregnancy in the United States, 1994 and 2001. Perspect. Sex. Reprod. Health. 2006;38:90–96. [PubMed] [Google Scholar]

18. Ray J.G., Singh G., Burrows R.F. Evidence for suboptimal use of periconceptional folic acid supplements globally. BJOG. 2004;111:399–408. [PubMed] [Google Scholar]

19. Crozier S.R., Robinson S.M., Borland S.E., Godfrey K.M., Cooper C., Inskip H.M. Do women change their health behaviours in pregnancy? Findings from the Southampton Women’s Survey. Paediatr. Perinat. Epidemiol. 2009;23:446–453. [PMC free article] [PubMed] [Google Scholar]

20. Botto L.D., Lisi A., Robert-Gnansia E., Erickson J.D., Vollset S.E., Mastroiacovo P., Botting B., Cocchi G., de Vigan C., de Walle H., et al. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: Are the recommendations working? BMJ. 2005;330:571. [PMC free article] [PubMed] [Google Scholar]

21. Dowd J.B., Aiello A.E. Did national folic acid fortification reduce socioeconomic and racial disparities in folate status in the US? Int. J. Epidemiol. 2008;37:1059–1066. doi: 10.1093/ije/dyn066. [PubMed] [CrossRef] [Google Scholar]

22. Flour Fortification Initiative, authors. Report of the Workshop of Wheat Flour Fortification: Cuernavaca, Mexico. [(accessed on August 21, 2010)]. Available online: http://www.sph.emory.edu/wheatflour/CKPAFF/index.htm.

23. Centers for Disease Control and Prevention, authors. CDC Grand Rounds: Additional Opportunities to Prevent Neural Tube Defects with Folic Acid Fortification. MMWR Morb. Mortal. Wkly. Rep. 2010;59:980–984. [PubMed] [Google Scholar]

24. Allen L., de Benoist B., Dary O., Hurrell R., editors. Guidelines on Food Fortification with Micronutrients. 1st. World Health Organization; Portland, OR, USA: 2006. Annex D—A procedure for estimating feasible fortification levels for a mass fortification programme; pp. 294–312. [Google Scholar]

25. Food and Drug Administration., authors Food standards: amendment of standards of identity for enriched grain products to require addition of folic acid. Final Rule. 21 CFR Parts 136, 137, and 139. Fed. Regist. 1996;61:8781–8789. [Google Scholar]

26. Quinlivan E.P., Gregory J.F., III. Reassessing folic acid consumption patterns in the United States (1999-2004): potential effect on neural tube defects and overexposure to folate. Am. J. Clin. Nutr. 2007;86:1773–1779. [PubMed] [Google Scholar]

27. Yang Q.H., Carter H.K., Mulinare J., Berry R.J., Friedman J.M., Erickson J.D. Race-ethnicity differences in folic acid intake in women of childbearing age in the United States after folic acid fortification: findings from the National Health and Nutrition Examination Survey, 2001–2002. Am. J. Clin. Nutr. 2007;85:1409–1416. [PubMed] [Google Scholar]

28. Rader J.I., Weaver C.M., Angyal G. Total folate in enriched cereal-grain products in the United States following fortification. Food Chem. 2000;70:275–289. [Google Scholar]

29. Berner L.A., Clydesdale F.M., Douglass J.S. Fortification contributed greatly to vitamin and mineral intakes in the United States, 1989–1991. J. Nutr. 2001;131:2177–2183. [PubMed] [Google Scholar]

30. Imhoff-Kunsch B., Flores R., Dary O., Martorell R. Wheat flour fortification is unlikely to benefit the neediest in Guatemala. J. Nutr. 2007;137:1017–1022. [PubMed] [Google Scholar]

31. Dary O. Establishing safe and potentially efficacious fortification contents for folic acid and vitamin B12. Food Nutr. Bull. 2008;29:S214–S224. [PubMed] [Google Scholar]

32. Berry R.J., Mulinare J., Hamner H.C. Folic acid fortification: neural tube defect risk reduction—a global perspective. In: Bailey L.B., editor. Folate in Health and Disease. 2nd. CRC Press; Boca Raton, FL, USA: 2010. pp. 179–204. [Google Scholar]

34. Chen L.T., Rivera M.A. The Costa Rican experience: reduction of neural tube defects following food fortification programs. Nutr. Rev. 2004;62:S40–S43. [PubMed] [Google Scholar]

35. Hertrampf E., Cortes F. Folic acid fortification of wheat flour: Chile. Nutr. Rev. 2004;62:S44–S48. doi: 10.1111/j.1753-4887.2004.tb00074.x. discussion S49. [PubMed] [CrossRef] [Google Scholar]

36. Sayed A.R., Bourne D., Pattinson R., Nixon J., Henderson B. Decline in the prevalence of neural tube defects following folic acid fortification and its cost-benefit in South Africa. Birth Defects Res. A Clin. Mol. Teratol. 2008;82:211–216. [PubMed] [Google Scholar]

37. Williams L.J., Mai C.T., Edmonds L.D., Shaw G.M., Kirby R.S., Hobbs C.A., Sever L.E., Miller L.A., Meaney F.J., Levitt M. Prevalence of spina bifida and anencephaly during the transition to mandatory folic acid fortification in the United States. Teratology. 2002;66:33–39. [PubMed] [Google Scholar]

38. Honein M.A., Paulozzi L.J., Mathews T.J., Erickson J.D., Wong L.Y. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA. 2001;285:2981–2986. [PubMed] [Google Scholar]

40. Boulet S.L., Yang Q., Mai C., Kirby R.S., Collins J.S., Robbins J.M., Meyer R., Canfield M.A., Mulinare J. Trends in the postfortification prevalence of spina bifida and anencephaly in the United States. Birth Defects Res. A Clin. Mol. Teratol. 2008;82:527–532. [PubMed] [Google Scholar]

41. de Wals P., Rusen I., Lee N., Morin P., Niyonsenga T. Trend in prevalence of neural tube defects in Quebec. Birth Defects Res. A Clin. Mol. Teratol. 2003;67:919–923. [PubMed] [Google Scholar]

42. Ray J., Meier C., Vermeulen M., Boss S., Wyatt P., Cole D. Association of neural tube defects and folic acid food fortification in Canada. Lancet. 2002;360:2047–2048. [PubMed] [Google Scholar]

43. Persad V.L., van den Hof M.C., Dube J.M., Zimmer P. Incidence of open neural tube defects in Nova Scotia after folic acid fortification. Can. Med. Assoc. J. 2002;167:241–245. [PMC free article] [PubMed] [Google Scholar]

44. Liu S., West R., Randell E., Longerich L., O’Connor K.S., Scott H., Crowley M., Lam A., Prabhakaran V., McCourt C. A comprehensive evaluation of food fortification with folic acid for the primary prevention of neural tube defects. BMC Pregnancy Childbirth. 2004;4:20. [PMC free article] [PubMed] [Google Scholar]

45. de Wals P., Tairou F., van Allen M.I., Uh S.H., Lowry R.B., Sibbald B., Evans J.A., van den Hof M.C., Zimmer P., Crowley M., Fernandez B., Lee N.S., Niyonsenga T. Reduction in neural-tube defects after folic acid fortification in Canada. N. Engl. J. Med. 2007;357:135–142. [PubMed] [Google Scholar]

46. Lopez-Camelo J.S., Castilla E.E., Orioli I.M. Folic acid flour fortification: impact on the frequencies of 52 congenital anomaly types in three South American countries. Am. J. Med. Genet. A. 2010;152A:2444–2458. [PubMed] [Google Scholar]

47. Molloy A.M., Kirke P.N., Troendle J.F., Burke H., Sutton M., Brody L.C., Scott J.M., Mills J.L. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic Acid fortification. Pediatrics. 2009;123:917–923. [PMC free article] [PubMed] [Google Scholar]

48. Selhub J., Jacques P.F., Dallal G., Choumenkovitch S., Rogers G. The use of blood concentrations of vitamins and their respective functional indicators to define folate and vitamin B12 status. Food. Nutr. Bull. 2008;29:S67–S73. [PubMed] [Google Scholar]

49. Daly L.E., Kirke P.N., Molloy A., Weir D.G., Scott J.M. Folate levels and neural tube defects. Implications for prevention. JAMA. 1995;274:1698–1702. [PubMed] [Google Scholar]

50. Yang Q., Cogswell M.E., Hamner H.C., Carriquiry A., Bailey L.B., Pfeiffer C.M., Berry R.J. Folic acid source, usual intake, and folate and vitamin B-12 status in US adults: National Health and Nutrition Examination Survey (NHANES) 2003–2006. Am. J. Clin. Nutr. 2010;91:64–72. [PubMed] [Google Scholar]

51. Clarke R., Halsey J., Lewington S., Lonn E., Armitage J., Manson J.E., Bonaa K.H., Spence J.D., Nygard O., Jamison R., et al. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals. Arch. Intern. Med. 2010;170:1622–1631. [PubMed] [Google Scholar]

52. Berry R.J., Carter H.K., Yang Q. Cognitive impairment in older Americans in the age of folic acid fortification. Am. J. Clin. Nutr. 2007;86:267–269. [PubMed] [Google Scholar]

53. Hunter R., Barnes J., Oakeley H.F., Matthews D.M. Toxicity of folic acid given in pharmacological doses to healthy volunteers. Lancet. 1970;1:61–63. [PubMed] [Google Scholar]

54. Gibberd F.B., Nicholls A., Dunne J.F., Chaput de Saintonge D.M. Toxicity of folic acid. Lancet. 1970;1:360–361. [PubMed] [Google Scholar]

55. Hellstrom L. Lack of toxicity of folic acid given in pharmacological doses to healthy volunteers. Lancet. 1971;1:59–61. [PubMed] [Google Scholar]

56. Richens A. Toxicity of folic acid. Lancet. 1971;1:912. [PubMed] [Google Scholar]

57. Sheehy T.W. Folic acid: lack of toxicity. Lancet. 1973;1:37. [PubMed] [Google Scholar]

58. Spies T.D., Suarez R.M., Suarez R., Jr., Hernandez-Morales F. The therapeutic effect of folic acid in tropical sprue. Science. 1946;104:75–76. [PubMed] [Google Scholar]

59. Bailey R.L., Dodd K.W., Gahche J.J., Dwyer J.T., McDowell M.A., Yetley E.A., Sempos C.A., Burt V.L., Radimer K.L., Picciano M.F. Total folate and folic acid intake from foods and dietary supplements in the United States: 2003–2006. Am. J. Clin. Nutr. 2010;91:231–237. [PMC free article] [PubMed] [Google Scholar]

60. Yeung L.F., Cogswell M.E., Carriquiry A.L., Bailey L.B., Pfeiffer C.M., Berry R.J. Contributions of enriched cereal-grain products, ready-to-eat cereals, and supplements to folic acid and vitamin B-12 usual intake and folate and vitamin B-12 status in US children: National Health and Nutrition Examination Survey (NHANES), 2003–2006. Am. J. Clin. Nutr. 2011;93:172–185. doi: 10.3945/ajcn.2010.30127. [PubMed] [CrossRef] [Google Scholar]

61. Dickinson C.J. Does folic acid harm people with vitamin B12 deficiency? QJM. 1995;88:357–364. [PubMed] [Google Scholar]

62. Mills J.L., Von Kohorn I., Conley M.R., Zeller J., Cox C., Williamson R.E., Dufour D.R. Low vitamin B-12 concentrations in patients without anemia: the effect of folic acid fortification of grain. Am. J. Clin. Nutr. 2003;77:1474–1477. [PubMed] [Google Scholar]

63. Metz J., McNeil A.R., Levin M. The relationship between serum cobalamin concentration and mean red cell volume at varying concentrations of serum folate. Clin. Lab. Haematol. 2004;26:323–325. [PubMed] [Google Scholar]

64. Wyckoff K.F., Ganji V. Proportion of individuals with low serum vitamin B-12 concentrations without macrocytosis is higher in the post folic acid fortification period than in the pre folic acid fortification period. Am. J. Clin. Nutr. 2007;86:1187–1192. [PubMed] [Google Scholar]

65. Chen J., Xu X., Liu A., Ulrich C.M. Folate and Cancer. Epidemiological Perspective. In: Bailey L.B., editor. Folate in Health and Disease. 2nd. CRC Press, Taylor & Francis Group; Boca Raton, FL, USA: 2009. pp. 205–233. [Google Scholar]

66. Eckhardt F., Beck S., Gut I.G., Berlin K. Future potential of the Human Epigenome Project. Expert Rev. Mol. Diagn. 2004;4:609–618. [PubMed] [Google Scholar]

67. Fraga M.F., Ballestar E., Paz M.F., Ropero S., Setien F., Ballestar M.L., Heine-Suner D., Cigudosa J.C., Urioste M., Benitez J., et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc. Natl. Acad. Sci. USA. 2005;102:10604–10609. [PMC free article] [PubMed] [Google Scholar]

68. Bjornsson H.T., Sigurdsson M.I., Fallin M.D., Irizarry R.A., Aspelund T., Cui H., Yu W., Rongione M.A., Ekstrom T.J., Harris T.B., et al. Intra-individual change over time in DNA methylation with familial clustering. JAMA. 2008;299:2877–2883. [PMC free article] [PubMed] [Google Scholar]

69. Baylin S.B. Tying it all together: Epigenetics, genetics, cell cycle, and cancer. Science. 1997;277:1948–1949. doi: 10.1126/science.277.5334.1948. [PubMed] [CrossRef] [Google Scholar]

70. Baylin S.B., Herman J.G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 2000;16:168–174. [PubMed] [Google Scholar]

71. Momparler R.L., Bovenzi V. DNA methylation and cancer. J. Cell. Physiol. 2000;183:145–154. [PubMed] [Google Scholar]

72. Feinberg A.P. Cancer epigenetics takes center stage. Proc. Natl. Acad. Sci. USA. 2001;98:392–394. [PMC free article] [PubMed] [Google Scholar]

73. Esteller M. Epigenetics in Cancer. N. Engl. J. Med. 2008;358:1148–1159. [PubMed] [Google Scholar]

75. Miremadi A., Oestergaard M.Z., Pharoah P.D.P., Caldas C. Cancer genetics of epigenetic genes. Hum. Mol. Genet. 2007;16:R28–R49. [PubMed] [Google Scholar]

76. Ciappio E., Mason J.B. Folate and carcinogenesis basic mechanisms. In: Bailey L.B., editor. Folate in Health and Disease. 2nd. CRC Press, Taylor & Francis Group; Boca Raton, FL, USA: 2009. pp. 235–262. [Google Scholar]

77. Edwards B.K., Ward E., Kohler B.A., Eheman C., Zauber A.G., Anderson R.N., Jemal A., Schymura M.J., Lansdorp-Vogelaar I., Seeff L.C., van Ballegooijen M., Goede S.L., Ries L.A. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116:544–573. [PMC free article] [PubMed] [Google Scholar]

78. EFSA: ESCO Report on Analysis of Risks and Benefits of Fortification of Food with Folic Acid. [(accessed on January 29, 2010)]. Available online: http://www.efsa.europa.eu/en/scdocs/scdoc/3e.htm.

79. Waterland R.A., Jirtle R.L. Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition. 2004;20:63–68. doi: 10.1016/j.nut.2003.09.011. [PubMed] [CrossRef] [Google Scholar]

80. Bailey L. Handbook of Vitamins. CRC Press, Taylor & Francis Group; Boca Raton, FL, USA: 2007. Folic Acid. [Google Scholar]

81. Sweeney M., McPartlin J., Scott J. Folic acid fortification and public health: Report on threshold doses above which unmetabolised folic acid appear in serum. BMC Public Health. 2007;7:41. [PMC free article] [PubMed] [Google Scholar]

82. Rock C.L. Multivitamin-multimineral supplements: who uses them? Am. J. Clin. Nutr. 2007;85:277S–279S. [PubMed] [Google Scholar]

83. Kelly P., McPartlin J., Goggins M., Weir D.G., Scott J.M. Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am. J. Clin. Nutr. 1997;65:1790–1795. [PubMed] [Google Scholar]

84. Sweeney M.R., McPartlin J., Weir D.G., Daly L., Scott J.M. Postprandial serum folic acid response to multiple doses of folic acid in fortified bread. Br. J. Nutr. 2006;95:145–151. [PubMed] [Google Scholar]

85. Kalmbach R.D., Choumenkovitch S.F., Troen A.M., D’Agostino R., Jacques P.F., Selhub J. Circulating folic acid in plasma: relation to folic acid fortification. Am. J. Clin. Nutr. 2008;88:763–768. [PMC free article] [PubMed] [Google Scholar]

86. Obeid R., Kirsch S.H., Kasoha M., Eckert R., Herrmann W. Concentrations of unmetabolized folic acid and primary folate forms in plasma after folic acid treatment in older adults. Metabolism. 2010 doi: 10.1016/j.metabol.2010.06.020. [PubMed] [CrossRef] [Google Scholar]

87. Bailey R.L., Mills J.L., Yetley E.A., Gahche J.J., Pfeiffer C.M., Dwyer J.T., Dodd K.W., Sempos C.T., Betz J.M., Picciano M.F. Unmetabolized serum folic acid and its relation to folic acid intake from diet and supplements in a nationally representative sample of adults aged ≥60 y in the United States. Am. J. Clin. Nutr. 2010;92:383–389. [PMC free article] [PubMed] [Google Scholar]

88. Obeid R., Kasoha M., Kirsch S.H., Munz W., Herrmann W. Concentrations of unmetabolized folic acid and primary folate forms in pregnant women at delivery and in umbilical cord blood. Am. J. Clin. Nutr. 2010;92:1287–1288. [PubMed] [Google Scholar]

89. Morris M.S., Jacques P.F., Rosenberg I.H., Selhub J. Circulating unmetabolized folic acid and 5-methyltetrahydrofolate in relation to anemia, macrocytosis, and cognitive test performance in American seniors. Am. J. Clin. Nutr. 2010;91:1733–1744. doi: 10.3945/ajcn.2009.28671. [PubMed] [CrossRef] [Google Scholar]

90. Scientific Advisory Committee on Nutrition, authors. Folate and Disease Prevention. The Stationary Office; Norwich, UK: 2006. [Google Scholar]

91. Food Safety Authority of Ireland, authors. Report of the National Committee on Folic Acid Food Fortification. [(accessed on October 1, 2010)]. Available online: http://www.fsai.ie/WorkArea/DownloadAsset.aspx?id=770.

93. Health Council of the Netherlands, authors. Health Council of the Netherlands. Health Council of the Netherlands; Hague, The Netherlands: 2008. Towards an optimal use of folic acid. [Google Scholar]

94. Scientific Advisory Committee on Nutrition, authors. Folic Acid and Colorectal Cancer Risk: Review of Recommendation for Mandatory Folic Acid Fortification. The Stationary Office; Norwich, UK: 2009. [Google Scholar]

96. Food Safety Authority of Ireland, authors. Report of the Implementation Group on Folic Acid Food Fortification to the Department of Health and Children. [(accessed on October 1, 2010)]. Available online: http://www.fsai.ie/WorkArea/DownloadAsset.aspx?id=7602.

97. Food Safety Authority of Ireland, authors. Currently No Need for Mandatory Fortification—Increased Folate Status Negates Mandatory Folic Acid Fortification at This Time. [(accessed on October 1, 2010)]. Available online: http://www.fsai.ie/news_centre/press_releases/11032009.html.

98. Berry R.J., Bailey L., Mulinare J., Bower C. Fortification of flour with folic acid. Food Nutr. Bull. 2010;31:S22–S35. [PubMed] [Google Scholar]

Which of the following nutrients is critical for preventing neural tube defects quizlet?

Which nutrient is critical for proper neural tube development?

Which B vitamin lowers the risk of neural tube defects in newborns quizlet?

When a deficiency in this vitamin occurs there is an increased chance of neural tube defects?